• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION AGILE ESOPHAGEAL OTW; PROSTHESIS, ESOPHAGEAL

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION AGILE ESOPHAGEAL OTW; PROSTHESIS, ESOPHAGEAL Back to Search Results
Device Problems Difficult to Remove (1528); Use of Device Problem (1670); Material Deformation (2976)
Patient Problem Hemorrhage/Bleeding (1888)
Event Date 12/08/2023
Event Type  Injury  
Manufacturer Narrative
Block d4, h4: the complainant was unable to provide the suspect device lot number.Therefore, the manufacture and expiration dates are unknown.Block h6: imdrf device code a150207 captures the reportable event of delivery system difficult to remove.Imdrf patient code e0506 captures the reportable event of major hemorrhage.Imdrf impact code f19 captures the reportable event of patient was sent to surgery.
 
Event Description
It was reported to boston scientific corporation that an agile biliary stent was to be implanted to treat emergent bleeding that was coming through a fistulous cavity possibly due to a splenic artery pseudoaneurysm during a procedure performed on (b)(6), 2023.The patient's anatomy was extremely tortuous.During the procedure, the stent delivery system got stuck on the proximal flange of the stent.The physician attempted to wiggle the catheter, however, the stent suture got caught on the catheter and the delivery system could not be removed.The stent delivery system was eventually removed.The patient was sent to surgery to treat the emergent bleeding.Note: it was reported that the agile stent was attempted to be implanted to treat a bleeding.However, per the agile esophageal partially covered and fully covered stent systems directions for use, the stent is indicated for maintaining esophageal luminal patency in esophageal strictures caused by intrinsic and/or extrinsic malignant tumors, and occlusion of concurrent esophageal fistula.The device is not indicated for bleeding.
 
Manufacturer Narrative
Block d4, h4: the complainant was unable to provide the suspect device lot number.Therefore, the manufacture and expiration dates are unknown.Block b5 was updated based on the additional information received on december 28, 2023.Block h6: imdrf device code a150207 captures the reportable event of delivery system difficult to remove.Imdrf patient code e0506 captures the reportable event of major hemorrhage.Imdrf impact code f19 captures the reportable event of patient was sent to surgery.
 
Event Description
It was reported to boston scientific corporation that an agile biliary stent was to be implanted to treat emergent bleeding that was coming through a fistulous cavity possibly due to a splenic artery pseudoaneurysm during a procedure performed on (b)(6) 2023.The patient's anatomy was extremely tortuous.During the procedure, the stent delivery system got stuck on the proximal flange of the stent.The physician attempted to wiggle the catheter, however, the stent suture got caught on the catheter and the delivery system could not be removed.The stent delivery system was eventually removed.The patient was sent to surgery to treat the emergent bleeding.Note: it was reported that the agile stent was attempted to be implanted to treat a bleeding.However, per the agile esophageal partially covered and fully covered stent systems directions for use, the stent is indicated for maintaining esophageal luminal patency in esophageal strictures caused by intrinsic and/or extrinsic malignant tumors, and occlusion of concurrent esophageal fistula.The device is not indicated for bleeding.The stent was to be implanted in the gastroesophageal (ge) junction.It was reported that there was no altered anatomy from gastric bypass and gastric sleeve.The emergency surgery was performed on the same day the agile stent was attempted to be implanted and the patient was reported to have recovered from the blood loss.
 
Manufacturer Narrative
Block d4, h4: the complainant was unable to provide the suspect device lot number.Therefore, the manufacture and expiration dates are unknown.Block h6: imdrf device code a150207 captures the reportable event of delivery system difficult to remove.Imdrf patient code e0506 captures the reportable event of major hemorrhage.Imdrf impact code f19 captures the reportable event of patient was sent to surgery.Block h11: block b5 has been corrected.
 
Event Description
It was reported to boston scientific corporation that an agile esophageal stent was to be implanted to treat emergent bleeding that was coming through a fistulous cavity possibly due to a splenic artery pseudoaneurysm during a procedure performed on (b)(6) 2023.The patient's anatomy was extremely tortuous.During the procedure, the stent delivery system got stuck on the proximal flange of the stent.The physician attempted to wiggle the catheter, however, the stent suture got caught on the catheter and the delivery system could not be removed.The stent delivery system was eventually removed.The patient was sent to surgery to treat the emergent bleeding.Note: it was reported that the agile stent was attempted to be implanted to treat a bleeding.However, per the agile esophageal partially covered and fully covered stent systems directions for use, the stent is indicated for maintaining esophageal luminal patency in esophageal strictures caused by intrinsic and/or extrinsic malignant tumors, and occlusion of concurrent esophageal fistula.The device is not indicated for bleeding.Additional information received on december 28, 2023: the stent was to be implanted in the gastroesophageal (ge) junction.There was no malignance, however, the patient had altered anatomy due to the reversal of gastric bypass & gastric sleeve procedures.The emergency surgery was performed on the same day the agile stent was attempted to be implanted and the patient was reported to have recovered from the blood loss.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
AGILE ESOPHAGEAL OTW
Type of Device
PROSTHESIS, ESOPHAGEAL
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
300 boston scientific way
marlborough MA 01752
Manufacturer (Section G)
BOSTON SCIENTIFIC CORPORATION
ballybrit business park
galway
EI  
Manufacturer Contact
carole morley
300 boston scientific way
marlborough, MA 01752
5086834015
MDR Report Key18438449
MDR Text Key331831300
Report Number3005099803-2023-06945
Device Sequence Number1
Product Code ESW
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K211960
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup,Followup
Report Date 04/08/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 12/08/2023
Initial Date FDA Received01/03/2024
Supplement Dates Manufacturer Received12/28/2023
03/25/2024
Supplement Dates FDA Received01/19/2024
04/08/2024
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient SexFemale
-
-